Please login to the form below
prescription drugs
This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.
Lilly joins new Medicare scheme to reduce insulin prices
That includes recent draft guidance published by the Trump administration which would allow states in the US to import prescription drugs from Canada to try to reduce cost, although that plan ... excludes biologics such as insulin as well as intravenous
Latest news
-
AbbVie/Allergan merger faces renewed public opposition despite divestments
AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and ... prevents “rival
-
Lilly extends range of cut-price insulins in the US
list price of the branded drugs – will be available in April, according to the company. ... Last month, the Trump administration published draft guidance which would allow states in the US to import prescription drugs from Canada to try to reduce
-
GSK, Pfizer and Sanofi among drugmakers planning price hikes in US
range. The price increases come amid intense public and political discourse over prescription drug prices in the US. ... The draft guidance would allow states in the US to import prescription drugs from Canada, as part of cost-saving efforts to combat
-
The year in review
And earlier this year, court documents revealed that Amazon may seriously be considering working directly with health plans and employers to sell prescription drugs – a move that would effectively allow it
-
Trump administration advances drug importation plan
Proposal would allow states to import drugs from Canada. The Trump administration has advanced draft guidance which would allow states in the US to import prescription drugs from Canada, as part ... The plan was initially announced back in July, and
More from news
Approximately 2 fully matching, plus 180 partially matching documents found.
Latest Intelligence
-
BRIC markets
prescription drugs is a problem,” he continued. ... Drugs that aren’t listed may maintain a higher price and the lack of access may not necessarily be a negative for them.”.
-
Drug launches to watch in 2019
11. Buvidal – an advance in opioid dependence treatment. Opioid addiction has surged in the US since the 1990s, when prescription drugs such as OxyContin and Vicodin became a common remedy for ... Now there is a growing need for treatments which can
-
Behaviour change – a missing ingredient?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
US health reforms
In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs
-
Re-awakening the emotion in healthcare communications
phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the
More from intelligence
Approximately 0 fully matching, plus 28 partially matching documents found.
Latest appointments
-
Keith Webber leaves FDA for Perrigo
Drug Evaluation and Research (CDER), which over-the-counter and prescription drugs. ... This includes holding responsibility for advancing the approval of drugs and providing guidance on regulatory strategy for products in development.
-
Genzyme’s Richard Moscicki joins FDA
prescription-only drugs available in the US.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Behaviour change – is there something missing?
There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or
-
How to build an online medical information service that resonates with your customers
However, as an increasing number of drugs have come off patent, there is a growing need for clinical and scientific medical information.Now more and more pharmaceutical companies are investing in ... Manufacturers are responsible for the way they respond
-
PEGASUS JOINS ASHFIELD HEALTHCARE COMMUNICATIONS
Sharp is also a world leader in ’Track and Trace’ serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability. .
-
How to design patient services with social media within the ABPI code guidelines
When designing digital services and informational materials for prescription drugs or services, there are unique considerations that must be taken around how that information is accessed and used. ... The code explains how use of social media to discuss
-
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?
drugs, whilst boosting generic drug prescription and supporting the domestic drug industry. ... Following the Act, any drug registered as a “similares” have to meet the same bioequivalence standards as generic drugs.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Lilly’s Verzenio scores a win in early-stage breast cancer
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- Keytruda doubles five-year survival rate in NSCLC
- FDA approves Roche’s Actemra COVID-19 trial
PMHub
Merrill Brink International
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
